)

Amarin Corporation (AMRN) investor relations material
Amarin Corporation Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Entered a long-term licensing and supply agreement with Recordati to accelerate Veskepa/VAZKEPA commercialization in Europe, shifting the core franchise to a partner with strong cardiovascular expertise and covering 59 countries.
Implemented a global restructuring plan following the Recordati deal, targeting $70M in annualized operating expense savings, primarily from European commercial role reductions, with a $22.8M restructuring charge recognized in Q2 2025.
Achieved solid product sales growth in Europe and other key markets year-over-year and sequentially, while maintaining tight expense control and a strong cash position of $298.7M with no debt.
U.S. business remains a significant cash generator with stable market share and exclusive accounts, despite ongoing generic competition and a 17% year-over-year sales decline.
Actively evaluating further strategic opportunities with Barclays as exclusive financial advisor to enhance shareholder value.
Financial highlights
Q2 2025 total net revenue was $72.7M, up 8% year-over-year, primarily due to the Recordati upfront payment.
Q2 2025 net product revenue was $46.6M, down 2% year-over-year, with U.S. revenue declining 17% and European revenue rising 85%–86%.
Q2 2025 licensing and royalty revenue was $26.1M, up 31% year-over-year, reflecting the Recordati payment and partner-driven demand.
Gross margin improved to 52% in Q2 2025 from 48% in Q2 2024, due to a favorable customer mix.
Ended the quarter with $298.7M in cash and investments, no debt, and sufficient inventory to meet global demand.
Outlook and guidance
Expect continued year-over-year revenue declines in the U.S. due to pricing pressure and PBM coverage loss, but focus remains on maximizing value through targeted execution and international growth.
Anticipate maintaining exclusive payer positions in the U.S. through 2025, with further clarity on 2026 expected later in the year.
Net price in the U.S. expected to remain stable as long as exclusives are maintained.
$70M in annualized cost savings from restructuring to be realized on a straight-line basis over the next four quarters.
Cash reserves projected to be sufficient to fund operations and the share repurchase program for at least one year.
Next Amarin Corporation earnings date

Next Amarin Corporation earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage